Risk alert: Birth control pills recalled

May 30, 2018 Laura Hale Brockway

Almost 170,000 sample packs of Taytulla birth control pills are being recalled because placebo and active capsules were packaged out of order, increasing the risk of unwanted pregnancy. The sample packs were distributed to physicians across the US.

According to the FDA recall notice, Allergan recently identified — through a physician report —  that four placebo capsules were placed out of order in a sample pack of Taytulla. Specifically, the first four days of therapy had four non-hormonal placebo capsules instead of active capsules.

The affected lot numbers and photos of the product are available from the FDA recall notice. Allergan is notifying customers by recall letter and advising women who have used a Taytulla sample pack from the recalled lot to consult with their physician.

Health care professionals are encouraged to report adverse events or side effects to the FDA's MedWatch Safety Information and Adverse Event Reporting Program.

About the Author

Laura Hale Brockway is the Assistant Vice President of Marketing at TMLT. She has more than 20 years of marketing and management experience, and has worked for Seton Healthcare Family and the Texas Academy of Family Physicians. Laura holds an Editor in Life Science (ELS) certification from the Board of Editors in the Life Sciences.

Visit Website More Content by Laura Hale Brockway
Previous Article
Risk alert: FDA relabels intragastric balloon systems due to possible related deaths
Risk alert: FDA relabels intragastric balloon systems due to possible related deaths

The FDA has approved new labeling for the Orbera and ReShape balloon systems.

Next Article
Recap: “How to Fight the Opioid Epidemic”
Recap: “How to Fight the Opioid Epidemic”

For this year’s spring CME seminars, attorney Brett B. Rowe presented “How to Fight the Opioid Epidemic” in...

WEBINAR: Budgeting for HIPAA & Cyber Security

Learn More